- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Riverside Today
By the People, for the People
Grace Therapeutics reports Q3 loss
The pharmaceutical company posted a $2.3 million loss in the latest quarter.
Published on Feb. 12, 2026
Got story updates? Submit your updates here. ›
Grace Therapeutics, Inc. reported a loss of $2.3 million in its fiscal third quarter, according to an Associated Press report. The pharmaceutical company is based in Princeton, New Jersey.
Why it matters
Grace Therapeutics is a publicly traded pharmaceutical company, so its quarterly financial results are closely watched by investors and analysts to gauge the company's performance and outlook.
The details
The $2.3 million loss reported by Grace Therapeutics for the third quarter is part of the company's regular financial reporting as a public company. Pharmaceutical companies often report losses, especially in earlier stages of drug development, before potentially becoming profitable.
- Grace Therapeutics reported its fiscal third quarter results on February 12, 2026.
The players
Grace Therapeutics, Inc.
A pharmaceutical company based in Princeton, New Jersey that develops and commercializes specialty drugs.
The takeaway
Quarterly financial results are an important indicator of a pharmaceutical company's progress, though losses are common in the early stages of drug development before potential profitability.
